KLRK1 and neoplasm: Since NKG2D ligands were in turn expressed at high levels by MDSCs, NKG2D.ζ-NK cells were able to eliminate the suppressive myeloid cells in the tumor, allowing anti-GD2 CAR T cells to persist and be active within the TME [89,91].